These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


396 related items for PubMed ID: 10385671

  • 41. Permanent loss of anti-HBc after reactivation of hepatitis B virus infection in an anti-HBs and anti-HBc-positive patient after allogeneic stem cell transplantation.
    Gärtner BC, Jung W, Welsch C, Fischinger J, Schubert J, Zeuzem S, Mueller-Lantzsch N, Wend UC, Gerlich WH.
    J Clin Virol; 2007 Feb; 38(2):146-8. PubMed ID: 17182277
    [Abstract] [Full Text] [Related]

  • 42. Immune reactions against hepatitis B viral antigens lead to the rejection of hepatocellular carcinoma in BALB/c mice.
    Chen SH, Hu CP, Lee CK, Chang C.
    Cancer Res; 1993 Oct 01; 53(19):4648-51. PubMed ID: 8402642
    [Abstract] [Full Text] [Related]

  • 43. [Hepatitis B virus DNA detection by means of polymerase chain reaction in patients with chronic hepatitis and hepatocellular carcinoma].
    Song Y, Pan W, Fan Z, Du P, Qi Z.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep 01; 11(3):220-2. PubMed ID: 15617333
    [Abstract] [Full Text] [Related]

  • 44. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient.
    Jeantet D, Chemin I, Mandrand B, Zoulim F, Trepo C, Kay A.
    Hepatology; 2002 May 01; 35(5):1215-24. PubMed ID: 11981772
    [Abstract] [Full Text] [Related]

  • 45. [High rate of hepatitis B virus DNA positivity in anti-HBc only-positive patients].
    Yildirim M, Yavuz MT, Ozdemir D, Behçet M, Sencan I.
    Mikrobiyol Bul; 2008 Jul 01; 42(3):535-6. PubMed ID: 18822901
    [Abstract] [Full Text] [Related]

  • 46. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors.
    Moore MD, McGarvey MJ, Russell RA, Cullen BR, McClure MO.
    J Gene Med; 2005 Jul 01; 7(7):918-25. PubMed ID: 15756649
    [Abstract] [Full Text] [Related]

  • 47. Hepatitis B virus DNA in serum of 'anti-HBc only'-positive healthy Lebanese blood donors: significance and possible implications.
    El-Zaatari M, Kazma H, Naboulsi-Majzoub M, Haidar M, Ramlawi F, Mahfoud Z, Ramia S.
    J Hosp Infect; 2007 Jul 01; 66(3):278-82. PubMed ID: 17540476
    [Abstract] [Full Text] [Related]

  • 48. Adeno-associated virus Rep78 protein inhibits Hepatitis B virus replication through regulation of the HBV core promoter.
    Liu T, Cong M, Wang P, Jia J, Liu Y, Hermonat PL, You H.
    Biochem Biophys Res Commun; 2009 Jul 17; 385(1):106-11. PubMed ID: 19410559
    [Abstract] [Full Text] [Related]

  • 49. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y, Song S, Liu C, Wang Y, Xian X, He Y, Wang J, Liu F, Sun S.
    Cell Immunol; 2007 May 17; 247(1):18-27. PubMed ID: 17707782
    [Abstract] [Full Text] [Related]

  • 50. Deletion of integrated hepatitis B virus genome and cellular flanking sequences in hepatocellular carcinoma cells in BALB/c mice.
    Chang PC, Hu CP, Chen SH, Wang-Wuu S, Chang C.
    Hepatology; 1995 Jun 17; 21(6):1504-9. PubMed ID: 7768493
    [Abstract] [Full Text] [Related]

  • 51. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication.
    Nakatake H, Chisaka O, Yamamoto S, Matsubara K, Koshy R.
    Virology; 1993 Aug 17; 195(2):305-14. PubMed ID: 8337816
    [Abstract] [Full Text] [Related]

  • 52. Adsorption and penetration of hepatitis B virus in a nonpermissive cell line.
    Qiao M, Macnaughton TB, Gowans EJ.
    Virology; 1994 Jun 17; 201(2):356-63. PubMed ID: 8184545
    [Abstract] [Full Text] [Related]

  • 53. Inhibition of viral replication by genetically engineered mutants of the duck hepatitis B virus core protein.
    von Weizsäcker F, Wieland S, Blum HE.
    Hepatology; 1996 Aug 17; 24(2):294-9. PubMed ID: 8690395
    [Abstract] [Full Text] [Related]

  • 54. Development of replicative and nonreplicative hepatitis B virus vectors.
    Chaisomchit S, Tyrrell DL, Chang LJ.
    Gene Ther; 1997 Dec 17; 4(12):1330-40. PubMed ID: 9472557
    [Abstract] [Full Text] [Related]

  • 55. Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro.
    Nakazono K, Ito Y, Wu CH, Wu GY.
    Hepatology; 1996 Jun 17; 23(6):1297-303. PubMed ID: 8675142
    [Abstract] [Full Text] [Related]

  • 56. An aptamer targets HBV core protein and suppresses HBV replication in HepG2.2.15 cells.
    Zhang Z, Zhang J, Pei X, Zhang Q, Lu B, Zhang X, Liu J.
    Int J Mol Med; 2014 Nov 17; 34(5):1423-9. PubMed ID: 25174447
    [Abstract] [Full Text] [Related]

  • 57. [Inhibition of hepatitis B viral gene expression and replication in vitro by targeted antisense oligonucleotides].
    Zhong S, Zhang D, Wen S.
    Zhonghua Yi Xue Za Zhi; 1995 Jul 17; 75(7):392-5, 444. PubMed ID: 7553155
    [Abstract] [Full Text] [Related]

  • 58. Poliovirus recombinants expressing hepatitis B virus antigens elicited a humoral immune response in susceptible mice.
    Yim TJ, Tang S, Andino R.
    Virology; 1996 Apr 01; 218(1):61-70. PubMed ID: 8615042
    [Abstract] [Full Text] [Related]

  • 59. Transbody against hepatitis B virus core protein inhibits hepatitis B virus replication in vitro.
    Wang Y, Li Y, Li N, Zhu Q, Hui L, Liu X, Han Q, Lv Y, Wang Q, Yang G, Zhou Z, Liu Z.
    Int Immunopharmacol; 2015 Apr 01; 25(2):363-9. PubMed ID: 25676532
    [Abstract] [Full Text] [Related]

  • 60. Carboxy-terminal truncations of the HBV core protein affect capsid formation and the apparent size of encapsidated HBV RNA.
    Beames B, Lanford RE.
    Virology; 1993 Jun 01; 194(2):597-607. PubMed ID: 7684872
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 20.